Skip to content

SAMHD1 Research Digest — 2026-05-03

Generated by samhd1_monitor | Model: claude-sonnet-4-6

Summary: 5 papers evaluated | 3 high-relevance (≥7) | 1 medium (5–6) | 1 low (3–4) | 0 scored <3

🔴 High Relevance (Score 7–10)

Added to Zotero automatically

Nucleotide metabolism reprogramming in obesity-associated cardiovascular inflammation: a new perspective (from Cardiology/Immunometabolism)
Taoming Qian; Mei Zhang; Yuhan Liu; Donghao Guo; Juan Jin — Frontiers in Immunology 2026
Score: 9/10 | Pathways: dNTPase, NLRP3, POLG-mtDNA, urate-NLRP3, treatment-target, clinical-phenotype, other

This paper directly models the SAMHD1-inhibition → cytosolic dNTP accumulation → mitochondrial dNTP import (SLC25/PNC transporters) → mtDNA oxidation → NLRP3 hyperactivation axis that is the PURPLE stream of the disease mechanism, proposes therapeutic nodes at SLC25 inhibition and SAMHD1-preserving kinase modulation, and validates the mechanistic framework in a cardiovascular/macrophage context highly relevant to the family's cardiac and inflammatory phenotypes.
DOI: 10.3389/fimmu.2026.1829718

Nickel exposure promotes aortic dissection progression by binding to VDAC1 and activating the cGAS-STING pathway in vascular smooth muscle cells. (from Cardiology/Vascular Surgery)
Xiao Zhihao; Jin Jing; Long Xiangxing; Zhu Xu; Jiao Jian — 2026
Score: 8/10 | Pathways: cGAS-STING, VDAC1, NLRP3, treatment-target, other

This paper directly demonstrates the VDAC1 oligomerization → mtDNA leakage → cGAS-STING activation axis in a cardiovascular cell type, mechanistically validating the BLUE stream of the SAMHD1 haploinsufficiency model, and identifies VBIT-12 (closely related to VBIT-4, a key treatment target in this disease) as an inhibitor of this pathway, providing direct mechanistic and therapeutic relevance.
DOI: 10.1016/j.jhazmat.2026.142122

SETD2 Deficiency Drives Mitochondrial DNA Leakage and Creates a Druggable Dependency on BCL-XL in Clear Cell Renal Cell Carcinoma. (from Oncology (clear cell renal cell carcinoma / tumor suppressor biology))
Uprety Anusha; Judd Chandler; Villella Emily D; Keller Rebecca; Wagner Ryan — 2026
Score: 7/10 | Pathways: cGAS-STING, VDAC1, BIK-cancer, POLG-mtDNA, treatment-target

This paper directly demonstrates the mechanistic link between cytoplasmic mtDNA leakage → cGAS-STING activation → IRF3 → apoptotic priming via BH3-only proteins (NOXA/MCL-1/BCL-xL), which parallels the BLUE and RED streams of the SAMHD1 A565T mechanism (VDAC1 macropore → mtDNA escape → cGAS-STING → IRF3), and also engages the BIK-cancer axis relevant to the family's solid tumor phenotypes, while introducing BCL-xL as a druggable synthetic lethal node downstream of chronic innate immune mtDNA sensing.
DOI: 10.1158/0008-5472.can-25-3195

🟡 Medium Relevance (Score 5–6)

Review and add to Zotero manually if warranted

ATP-Responsive Bimetallic Metal-Organic Frameworks Amplify Oxidative Stress in the Tumor Microenvironment for Synergistic Chemo-Immunotherapy. (from Oncology/Nanomedicine)
Li You; Zhang Wenxin; Xu Zitao; Ma Shixin; Xiong Yufei — 2026
Score: 5/10 | Pathways: cGAS-STING, VDAC1, POLG-mtDNA, other

This paper mechanistically demonstrates that Zn2+-induced mitochondrial dysfunction causes mtDNA leakage into the cytosol, activating cGAS-STING signaling—a core pathway in the SAMHD1 haploinsufficiency mechanism (BLUE stream via VDAC1 macropore → cytosolic mtDNA → cGAS → STING → IFN-I), but the context is entirely tumor-focused nanomedicine with no connection to SAMHD1, interferonopathy, or the family phenotype.
DOI: 10.3390/jfb17040199

🟢 Low Relevance (Score 3–4)

Potential specialty bridges — skim titles

GE11/RGD Dual-Ligand Copper Nanoassemblies Synchronize Cuproptosis and Photothermal Therapy for Targeted Cervical Cancer Ablation. (from Oncology/nanomedicine)
Yang Nan; Liu Lu; Ding Lu; Chen Zhen; Su Tianyuan — 2026
Score: 4/10 | Pathways: cGAS-STING, POLG-mtDNA, other

The paper demonstrates that mtDNA leakage from mitochondrial collapse activates the cGAS-STING-IRF3 pathway as an anti-tumor mechanism, which is mechanistically relevant to the BLUE stream of the disease model, but in the context of copper-induced cuproptosis in cervical cancer with no connection to SAMHD1, interferonopathy, or the family phenotype.
DOI: 10.1021/acs.molpharmaceut.6c00002

Pathway Coverage This Week

  • POLG-mtDNA: 4 papers
  • other: 4 papers
  • cGAS-STING: 4 papers
  • treatment-target: 3 papers
  • VDAC1: 3 papers
  • NLRP3: 2 papers
  • dNTPase: 1 papers
  • urate-NLRP3: 1 papers
  • clinical-phenotype: 1 papers
  • BIK-cancer: 1 papers